Abstract:Asthma is a chronic pulmonary disease, highly associated with immune disorders. The typical symptoms of asthma include airway hyperresponsiveness (AHR), airway remodeling, mucus overproduction, and airflow limitation. The etiology of asthma is multifactorial and affected by genetic and environmental factors. Increasing trends toward dysbiosis, smoking, stress, air pollution, and a western lifestyle may account for the increasing incidence of asthma. Based on the presence or absence of eosinophilic inflammation, asthma is mainly divided into T helper 2 (Th2) and non-Th2 asthma. Th2 asthma is mediated by allergen-specific Th2 cells, and eosinophils activated by Th2 cells via the secretion of interleukin (IL)-4, IL-5, and IL-13. Different from Th2 asthma, non-Th2 asthma shows little eosinophilic inflammation, resists to corticosteroid treatment, and occurs mainly in severe asthmatic patients. Previous studies of asthma primarily focused on the function of Th2 cells, but, with the discovery of non-Th2 asthma and the involvement of innate lymphoid cells (ILCs) in the pathogenesis of asthma, tissue-resident innate immune cells in the lung have become the focus of attention in asthma research. Currently, innate-like lymphocytes (ILLs) and ILCs as important components of the innate immune system in mucosal tissues are reportedly involved in the pathogenesis of or protection against both Th2 and non-Th2 asthma. These findings of the functions of different subsets of ILLs and ILCs may provide clues for the treatment of asthma.

Research progress on type Ⅱ innate lymphoid cells in respiratory mucosal immunity and lung diseases

The Origin and Role of Innate Lymphoid Cells in the Lung

The Role of ILC3 in Intestinal Immunity

A crosstalk between type 2 innate lymphoid cells and alternative macrophages in lung development and lung diseases (Review)

Modulating ILC2 function for treatment of type 2 airway diseases

Research Progress on the Role of Innate Lymphocytes in Chronic Obstructive Pulmonary Disease

Maturation and specialization of group 2 innate lymphoid cells through the lung-gut axis

The Role of Type 2 Innate Lymphoid Cells in Allergic Diseases

New insights into the function, development, and plasticity of type 2 innate lymphoid cells

Guards at the gate: physiological and pathological roles of tissue-resident innate lymphoid cells in the lung

Neural Regulation of Interactions Between Group 2 Innate Lymphoid Cells and Pulmonary Immune Cells

Functions of Group 2 Innate Lymphoid Cells in Tumor Microenvironment

[Type 2 Innate Lymphoid Cells and Chronic Rhinosinusitis].

Interferons as negative regulators of ILC2s in allergic lung inflammation and respiratory viral infections

The Role of Group 3 Innate Lymphoid Cells in Lung Infection and Immunity

LUNG group 2 innate lymphoid cells as a new adjuvant target to enhance intranasal vaccine efficacy against influenza

The production, function, and clinical applications of IL-33 in type 2 inflammation-related respiratory diseases

The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms

Heterogeneity of Group 2 Innate Lymphoid Cells Defines Their Pleiotropic Roles in Cancer, Obesity, and Cardiovascular Diseases

Innate-like Lymphocytes and Innate Lymphoid Cells in Asthma

The role of innate lymphoid cells in inlfammatory dermatosis